Search Within

Advanced Practice Providers

  1. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (220)
  2. Journal Article (109)
  3. Research Letter (7)
  4. Book Section (1)
  5. Correspondence (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (339)
  2. Department of Medicine (313)
  3. Hematologic Malignancies, Division of (301)
  4. Nursing (274)
  5. Survivorship Research (192)
  6. Bone Marrow Transplant (179)

More Groups

People
  1. Sergio Giralt (98)
  2. Miguel-Angel Perales (77)
  3. Gunjan Shah (68)
  4. Sean Devlin (68)
  5. Craig Sauter (63)
  6. Maria Palomba (61)

More People

Years
  1. 2025 (4)
  2. 2024 (14)
  3. 2023 (18)
  4. 2022 (22)
  5. 2021 (36)
  6. 2020 (26)

More Years

Publications
  1. Blood (106)
  2. Biology of Blood and Marrow Transplantation (51)
  3. Journal of Clinical Oncology (31)
  4. Bone Marrow Transplantation (12)
  5. Pediatric Blood and Cancer (11)
  6. Hematological Oncology (10)

More Publications

Publishers
  1. American Society of Hematology (113)
  2. Elsevier Inc. (67)
  3. American Society of Clinical Oncology (34)
  4. Nature Publishing Group (21)
  5. Wiley Blackwell (16)
  6. Oxford University Press (15)

More Publishers

Results (339)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ruxolitinib promotes clinical responses in large granular lymphocytic leukemia via suppression of JAK/STAT-dependent inflammatory cascades
    Meeting Abstract

    Moskowitz, A.; Rahman, J.; Ganesan, N.; Hannigan, K.; Ksanznak, K.; Bitton, H.; Lin, Y. H.; Davey, T.; Hancock, H.; Perez, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Low target antigen expression mediates resistance to BCMA CAR T cell therapy
    Meeting Abstract

    Perica, K.; Nataraj, S.; Sjojstrand, M. L.; Nagel, K.; Pavkovic, E.; Payson, E.; Cuenca, A.; Patel, A.; Chung, D.; Mailankody, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Journal Article

    Dahi, P. B.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Chinapen, S. A.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
    Journal Article

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia
    Journal Article

    Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
    NEJM Evidence (2023)

    Fulltext@MSK | Save
  • Critically Ill hematopoietic stem cell transplantation patient: Provider burnout and support
    Book Section

    Sitner, N. C.; Tipian, C. C.; Jakubowski, A. A.; Pastores, S. M.
    In Soubani. A. O. (Eds.) Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation (2023)

    Fulltext@MSK | Save